JP2014506900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506900A5 JP2014506900A5 JP2013555798A JP2013555798A JP2014506900A5 JP 2014506900 A5 JP2014506900 A5 JP 2014506900A5 JP 2013555798 A JP2013555798 A JP 2013555798A JP 2013555798 A JP2013555798 A JP 2013555798A JP 2014506900 A5 JP2014506900 A5 JP 2014506900A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- tapentadol
- criteria
- hcl
- result
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 description 5
- 229960005126 tapentadol Drugs 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161449329P | 2011-03-04 | 2011-03-04 | |
| US61/449,329 | 2011-03-04 | ||
| EP11003603.5 | 2011-05-03 | ||
| EP11003603 | 2011-05-03 | ||
| PCT/EP2012/000906 WO2012119729A1 (en) | 2011-03-04 | 2012-03-02 | Semisolid aqueous pharmaceutical composition containing tapentadol |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016200663A Division JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506900A JP2014506900A (ja) | 2014-03-20 |
| JP2014506900A5 true JP2014506900A5 (enExample) | 2016-09-01 |
| JP6027549B2 JP6027549B2 (ja) | 2016-11-16 |
Family
ID=44652117
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013555798A Expired - Fee Related JP6027549B2 (ja) | 2011-03-04 | 2012-03-02 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2016200663A Expired - Fee Related JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2017228602A Expired - Fee Related JP6670283B2 (ja) | 2011-03-04 | 2017-11-29 | タペンタドールを含む半固形の水性医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016200663A Expired - Fee Related JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2017228602A Expired - Fee Related JP6670283B2 (ja) | 2011-03-04 | 2017-11-29 | タペンタドールを含む半固形の水性医薬組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US9446008B2 (enExample) |
| EP (3) | EP3766489B1 (enExample) |
| JP (3) | JP6027549B2 (enExample) |
| KR (2) | KR102039320B1 (enExample) |
| CN (1) | CN103501774A (enExample) |
| AU (2) | AU2012224954C1 (enExample) |
| BR (1) | BR112013022556A8 (enExample) |
| CA (1) | CA2828637C (enExample) |
| CY (1) | CY1119725T1 (enExample) |
| DK (1) | DK2680834T3 (enExample) |
| EA (2) | EA025194B1 (enExample) |
| ES (2) | ES2910085T3 (enExample) |
| HR (1) | HRP20171836T1 (enExample) |
| HU (1) | HUE037491T2 (enExample) |
| IL (2) | IL227826B (enExample) |
| LT (1) | LT2680834T (enExample) |
| MX (2) | MX374468B (enExample) |
| NO (1) | NO2680834T3 (enExample) |
| PL (1) | PL2680834T3 (enExample) |
| PT (2) | PT3766489T (enExample) |
| RS (1) | RS56692B1 (enExample) |
| SI (1) | SI2680834T1 (enExample) |
| WO (1) | WO2012119729A1 (enExample) |
| ZA (1) | ZA201306480B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103501773A (zh) | 2011-03-04 | 2014-01-08 | 格吕伦塔尔有限公司 | 用于口服给予的他喷他多含水药物制剂 |
| NO2680834T3 (enExample) | 2011-05-03 | 2018-03-17 | ||
| US9395306B2 (en) | 2011-08-05 | 2016-07-19 | Halliburton Energy Services, Inc. | Methods for monitoring fluids within or produced from a subterranean formation during acidizing operations using opticoanalytical devices |
| US8997860B2 (en) | 2011-08-05 | 2015-04-07 | Halliburton Energy Services, Inc. | Methods for monitoring the formation and transport of a fracturing fluid using opticoanalytical devices |
| US8619256B1 (en) | 2012-09-14 | 2013-12-31 | Halliburton Energy Services, Inc. | Systems and methods for monitoring the properties of a fluid cement composition in a flow path |
| US20140076550A1 (en) | 2012-09-14 | 2014-03-20 | Halliburton Energy Services, Inc. | Systems and Methods for Detecting Microannulus Formation and Remediation |
| US9228940B2 (en) | 2012-09-14 | 2016-01-05 | Halliburton Energy Services, Inc. | Systems, methods, and apparatuses for in situ monitoring of cement fluid compositions and setting processes thereof |
| WO2015014980A1 (en) * | 2013-08-02 | 2015-02-05 | Ratiopharm Gmbh | Composition comprising tapentadol in a dissolved form |
| EP2845625A1 (en) | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| ES2710299T3 (es) | 2015-03-27 | 2019-04-24 | Gruenenthal Gmbh | Formulación estable para la administración parenteral de tapentadol |
| ES3027562T3 (en) * | 2016-09-23 | 2025-06-16 | Gruenenthal Gmbh | Stable formulation for parenteral administration of tapentadol |
| EP3826631A1 (en) * | 2018-07-24 | 2021-06-02 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Topical emulsion of an anticholinergic compound |
| MX2021011355A (es) | 2019-03-18 | 2021-10-13 | Sunstar Americas Inc | Composicion para cuidado oral. |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775678A (en) * | 1984-10-01 | 1988-10-04 | Schering Corporation | Clotrimazole cream |
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6183758B1 (en) * | 1998-01-29 | 2001-02-06 | Highland Laboratories, Inc. | Phytochemicals, nutrients & medication absorption &/or treatment |
| US6399087B1 (en) | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
| DE10109763A1 (de) | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| PL223471B1 (pl) | 2002-03-15 | 2016-10-31 | Cypress Bioscience Inc | Kompozycja farmaceutyczna zawierająca milnacypran do stosowania w leczeniu zespołu nadwrażliwości jelita grubego |
| US20030191187A1 (en) | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
| WO2004024126A1 (en) | 2002-09-13 | 2004-03-25 | Cydex, Inc. | Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| US20040180915A1 (en) | 2003-03-14 | 2004-09-16 | Xanodyne Pharmacal, Inc. | Methadone-containing compositions for parenteral administration and method of use thereof |
| WO2005112926A1 (en) | 2004-05-17 | 2005-12-01 | Pharmacofore, Inc. | Compositions and methods for treating or preventing pain |
| DE602004007905T2 (de) | 2004-06-28 | 2008-05-08 | Grünenthal GmbH | Kristalline Formen von (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid |
| JP5700904B2 (ja) | 2004-07-01 | 2015-04-15 | グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | （１ｒ，２ｒ）−３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）フェノールを含有する乱用防止経口投与形態物 |
| CA2606947A1 (en) | 2005-04-28 | 2006-11-02 | Theraquest Biosciences Llc | Methods and compositions for treating pain |
| TWI329334B (en) | 2005-12-02 | 2010-08-21 | Chung Shan Inst Of Science | Manufacture method of electromagnetic interference layer for the plasma display panel |
| US20080039405A1 (en) * | 2006-04-25 | 2008-02-14 | Croda, Inc. | Modification of percutaneous absorption of topically active materials |
| EP2012764B1 (en) | 2006-04-28 | 2011-01-12 | Grünenthal GmbH | Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol |
| PT2012763E (pt) | 2006-04-28 | 2011-04-29 | Gruenenthal Gmbh | Combinação farmacêutica que compreende 3-(3-dimetilamino-1-etil-2-metil-propil)fenol e um aine |
| CA2656696C (en) | 2006-07-24 | 2013-06-11 | Janssen Pharmaceutica N.V. | Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine |
| DE102007012165A1 (de) | 2007-03-12 | 2008-09-18 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes |
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| KR101607112B1 (ko) * | 2007-11-23 | 2016-03-29 | 그뤼넨탈 게엠베하 | 타펜타돌 조성물 |
| US8383152B2 (en) | 2008-01-25 | 2013-02-26 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| ES2758831T3 (es) * | 2008-10-30 | 2020-05-06 | Gruenenthal Gmbh | Nuevas y potentes formas de dosificación de tapentadol |
| US20100227921A1 (en) | 2009-03-03 | 2010-09-09 | Shire Llc | Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof |
| US20100272815A1 (en) | 2009-04-28 | 2010-10-28 | Actavis Group Ptc Ehf | Amorphous form of tapentadol hydrochloride |
| US20110190267A1 (en) * | 2010-01-05 | 2011-08-04 | Shire Pharmaceuticals, Inc. | Prodrugs of opioids and uses thereof |
| EP2552486B1 (en) * | 2010-03-30 | 2020-08-12 | Phosphagenics Limited | Transdermal delivery patch |
| GB201006200D0 (en) | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| US20120270848A1 (en) * | 2010-10-22 | 2012-10-25 | Galleon Pharmaceuticals, Inc. | Novel Compositions and Therapeutic Methods Using Same |
| NO2680834T3 (enExample) | 2011-05-03 | 2018-03-17 |
-
2012
- 2012-03-02 NO NO12710026A patent/NO2680834T3/no unknown
- 2012-03-02 JP JP2013555798A patent/JP6027549B2/ja not_active Expired - Fee Related
- 2012-03-02 EP EP20188822.9A patent/EP3766489B1/en active Active
- 2012-03-02 US US13/410,837 patent/US9446008B2/en active Active
- 2012-03-02 CA CA2828637A patent/CA2828637C/en not_active Expired - Fee Related
- 2012-03-02 DK DK12710026.1T patent/DK2680834T3/en active
- 2012-03-02 ES ES20188822T patent/ES2910085T3/es active Active
- 2012-03-02 SI SI201231143T patent/SI2680834T1/en unknown
- 2012-03-02 KR KR1020187029861A patent/KR102039320B1/ko not_active Expired - Fee Related
- 2012-03-02 PT PT201888229T patent/PT3766489T/pt unknown
- 2012-03-02 CN CN201280011678.9A patent/CN103501774A/zh active Pending
- 2012-03-02 BR BR112013022556A patent/BR112013022556A8/pt not_active Application Discontinuation
- 2012-03-02 EA EA201300988A patent/EA025194B1/ru not_active IP Right Cessation
- 2012-03-02 HU HUE12710026A patent/HUE037491T2/hu unknown
- 2012-03-02 KR KR1020137026185A patent/KR101911362B1/ko not_active Expired - Fee Related
- 2012-03-02 ES ES12710026.1T patent/ES2654407T3/es active Active
- 2012-03-02 PL PL12710026T patent/PL2680834T3/pl unknown
- 2012-03-02 EP EP17189139.3A patent/EP3290029B1/en active Active
- 2012-03-02 MX MX2016016703A patent/MX374468B/es unknown
- 2012-03-02 EA EA201600442A patent/EA033171B1/ru not_active IP Right Cessation
- 2012-03-02 EP EP12710026.1A patent/EP2680834B1/en active Active
- 2012-03-02 HR HRP20171836TT patent/HRP20171836T1/hr unknown
- 2012-03-02 AU AU2012224954A patent/AU2012224954C1/en not_active Ceased
- 2012-03-02 LT LTEP12710026.1T patent/LT2680834T/lt unknown
- 2012-03-02 PT PT127100261T patent/PT2680834T/pt unknown
- 2012-03-02 RS RS20171334A patent/RS56692B1/sr unknown
- 2012-03-02 MX MX2013010100A patent/MX344473B/es active IP Right Grant
- 2012-03-02 WO PCT/EP2012/000906 patent/WO2012119729A1/en not_active Ceased
-
2013
- 2013-08-06 IL IL227826A patent/IL227826B/en active IP Right Grant
- 2013-08-28 ZA ZA2013/06480A patent/ZA201306480B/en unknown
-
2016
- 2016-08-10 US US15/232,841 patent/US20160346229A1/en not_active Abandoned
- 2016-10-12 JP JP2016200663A patent/JP6259042B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-04 AU AU2017200040A patent/AU2017200040B2/en not_active Ceased
- 2017-11-29 JP JP2017228602A patent/JP6670283B2/ja not_active Expired - Fee Related
-
2018
- 2018-01-03 CY CY20181100006T patent/CY1119725T1/el unknown
- 2018-01-10 US US15/867,330 patent/US20180133174A1/en not_active Abandoned
- 2018-03-26 IL IL258357A patent/IL258357A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014506900A5 (enExample) | ||
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| WO2014182566A3 (en) | Preservation system for nutritional substances | |
| JP2014518878A5 (enExample) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| WO2016142224A8 (en) | Fungicidal mixtures comprising strobilurin-type fungicides | |
| WO2015171460A3 (en) | Formulations of cyclophosphamide liquid concentrate | |
| WO2015003082A3 (en) | Volatile organic compound formulations having antimicrobial activity | |
| MX366097B (es) | Mezclas conservantes sinergicas. | |
| WO2014169003A3 (en) | Multi-functional composition for cosmetic formulations | |
| WO2017069820A3 (en) | Antimicrobial composition having efficacy against endospores | |
| WO2012131117A8 (es) | Utilización de antifúngicos naturales para prevenir la infección de lesiones, injertos y heridas de poda en plantas leñosas por hongos fitopatógenos | |
| JP2017531030A5 (enExample) | ||
| MX2015011118A (es) | Extracto de cafe que contiene acido protocatecuico y su uso en agroquimica contra patogenos de plantas. | |
| RU2010146997A (ru) | Фармацевтическая композиция, содержащая силденафил и/или алпростадил, миноксидил и/или эуфиллин, тестостерон и/или йохимбин и липосомы для местного применения | |
| WO2016113752A3 (en) | Liquid formulation of cabazitaxel | |
| WO2015198265A3 (en) | Disinfectant and antimicrobial compositions, in particular for the veterinary field | |
| JP2020521060A5 (enExample) | ||
| PH12013502250A1 (en) | Construction material preservative | |
| WO2012169860A3 (ko) | 콩 추출물을 포함하는 탈모 방지 또는 육모 촉진용 조성물 | |
| WO2014137231A3 (en) | Totarol extract formulations and uses thereof | |
| JP2017537980A5 (enExample) | ||
| IN2014MU00284A (enExample) | ||
| EA202090950A1 (ru) | Композиция для облегчения похмелья, содержащая конъюгат сезамола и пептида в качестве активного ингредиента | |
| JP2014159381A5 (enExample) |